NF-κB activation and modulation in hepatic macrophages during cholestatic injury

Journal of Surgical Research

Volumn 72, Issue 2, 1997, Pages 129-134

  Fox, Eben S ^a   Kim, Jenny C ^a   Tracy Jr , Thomas F ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; ANTIOXIDANT; CYCLOHEXIMIDE; DEXAMETHASONE; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN INHIBITOR; REGULATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; ALPHA TOCOPHEROL; DRUG DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; CHOLESTATIC HEPATITIS; CONTROLLED STUDY; LIVER CELL; MACROPHAGE ACTIVATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANALYSIS OF VARIANCE; ANIMAL; CELL CULTURE; CHEMISTRY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETICS; INTRAHEPATIC CHOLESTASIS; LIVER; MACROPHAGE; METABOLISM; NORTHERN BLOTTING; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; BLOTTING, NORTHERN; CELLS, CULTURED; CHOLESTASIS, INTRAHEPATIC; CYCLOHEXIMIDE; DEXAMETHASONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; LIVER; MACROPHAGES; MALE; NF-KAPPA B; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN E;

EID: 0030612736     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1997.5172     Document Type: Article

References (45)

1. Laskin D. L., Pendino K. J. Macrophages and inflammatory mediators in tissue injury. Annu. Rev. Pharmacol. Toxicol. 35:1995;655.
2. Baeuerle P. A., Henkel T. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:1994;141.
3. Jaeschke H. Mechanisms of oxidant stress-induced acute tissue injury. Proc. Soc. Exp. Biol. Med. 209:1995;104.
4. 4. Hepatology. 22:1995;1474.
5. Suzuki Y. J., Packer L. Inhibition of NF-kappa B activation by vitamin E derivatives. Biochem. Biophys. Res. Commun. 193:1993;277.
6. Suzuki Y. J., Packer L. Inhibition of NF-kappa B DNA binding activity by alpha-tocopheryl succinate. Biochem. Mol. Biol. Int. 31:1993;693.
7. Neuschwander-Tetri B. A., Bellezzo J. M., Britton R. S., Bacon B. R., Fox E. S. Thiol regulation of endotoxin-induced tumor necrosis factor release from isolated Kupffer cells. Biochem. J. 320:1996;1005.
8. Ohtsuka T., Kubota A., Hirano T., Watanabe K., Yoshida H., Tsurufuji M., Iizuka Y., Konishi K., Tsurufuji S. Glucocorticoid-mediated gene suppression of rat cytokine-induced neutrophil chemoattractant CINC/gro, a member of the interleukin-8 family, through impairment of NFκB activation. J. Biol. Chem. 271:1996;1651.
9. Marx J. How the glucocorticoids suppress immunity. Science. 270:1995;232.
10. Scheinman R. I., Cogswell P. C., Lofquist A. K., Baldwin A. S. Jr. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science. 270:1995;283.
11. Auphan N., DiDonato J. A., Rosette C., Helmberg A., Karin M. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκB synthesis. Science. 270:1995;286.
12. Adcock I. M., Shirasaki H., Gelder C. M., Peters M. J., Brown C. R., Barnes P. J. The effects of glucocorticoids on phorbol ester and cytokine stimulated transcription factor activation in human lung. Life Sciences. 55:1994;1147.
13. Kleinert H., Euchenhofer C., Ihrig-Biedert I., Forstermann U. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B. Mol. Pharmacol. 49:1996;15.
14. Mukaida N., Morita M., Ishikawa Y., Rice N., Okamoto S., Kasahara T., Matsushima K. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J. Biol. Chem. 269:1994;13289.
15. Fox E. S., Tracy T. F. Jr. Alterations in tumor necrosis factor-α expression by hepatic macrophages following acute cholestatic liver injury. Shock. 5:1996;112.
16. Tracy T. F. Jr., Dillon P., Fox E. S., Minnick K., Vogler C. The inflammatory response in pediatric biliary disease: Macrophage phenotype and distribution. J. Ped. Surg. 31:1996;121.
17. Tracy T. F. Jr., Fox E. S. CD14-lipopolysaccharide receptor activity in hepatic macrophages after cholestatic liver injury. Surgery. 118:1995;371.
18. Tilg H., Wilmer A., Vogel W., Herold M., Nolchen B., Judmaier G., Huber C. Serum levels of cytokines in chronic liver disease. Gastroenterology. 103:1992;264.
19. Adams D. H., Hubscher S. G., Shaw J., Johnson G. D., Babbs C., Rothlein R., Neuberger J. M. Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology. 14:1991;426.
20. Dillon P., Belchis D., Tracy T., Cilley R., Hafer L., Krummel T. Increased expression of intercellular adhesion molecules in biliary atresia. Am. J. Pathol. 145:1994;263.
21. Essani N. A., Fisher M. A., Farhood A., Manning A. M., Smith C. W., Jaeschke H. Cytokine-induced upregulation of hepatic intercellular adhesion molecule-1 messenger RNA expression and its role in the pathophysiology of murine endotoxin shock and acute liver failure. Hepatology. 21:1995;1632.
22. Morita M., Watanabe Y., Akaike T. Inflammatory cytokines up-regulate intercellular adhesion molecule-1 expression on primary cultured mouse hepatocytes and T-lymphocyte adhesion. Hepatology. 19:1994;426.
23. Schreck R., Albermann K., Baeuerle P. A. Nuclear factor kappa B: An oxidative stress-responsive transcription factor of eukaryotic cells. Free Rad. Res. Commun. 17:1992;221.
24. Knook D., Slyster C. Separation of Kupffer cells and endothelial cells of the rat liver by centrifugal elutriation. Exp. Cell Res. 99:1976;494.
25. Brown C. W., McHugh K. M., Lessard J. L. A cDNA sequence encoding cytoskeletal gamma actin from rat. Nucleic Acids Res. 18:1990;5312.
26. Haskill S., Beg A. A., Tompkins S. M., Morris J. S., Yurochko A. D., Sampson-Johannes A., Mondal K., Ralph P., Baldwin A. S. Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity. Cell. 65:1991;1281.
27. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor. p. 7.37-7.58.
28. Bellezzo J. M., Britton R. S., Bacon B. R., Fox E. S. Lipopolysaccharide-mediated NF-κB activation in rat Kupffer cells can be induced independently of CD14. Am. J. Physiol. 270:1996;G956.
29. Bradford M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248.
30. Aldana P. R., Goerke M. E., Carr S. C., Tracy T. F. The expression of regenerative growth factors in chronic liver injury and repair. J. Surg. Res. 57:1994;711.
31. Sokol R. J., Devereaux M., Khandwala A. Effects of dietary lipid and vitamin E on mitochondrial lipid peroxidation and hepatic injury in the bile duct-ligated rat. J. Lipid Res. 32:1991;1349.
32. Hass R., Brach M., Gunji H., Kharbanda S., Kufe D. Inhibition of EGR-1 and NF-kappa B gene expression by dexamethasone during phorbol ester-induced human monocytic differentiation. Biochem. Pharmacol. 44:1992;1569.
33. Fox E. S., Brower J. S., Bellezzo J. M., Leingang K. A. N. J. Immunol. 158:1997;5418.
34. Shakhov A. N., Collart M. A., Vassalli P., Nedospasov S. A., Jongeneel C. V. κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages. J. Exp. Med. 171:1990;35.
35. Arthur M. J. P., Bently I. S., Tanner A. R., Saunders P. K., Millward-Sadler G. H., Wright R. Oxygen-derived free radicals promote hepatic injury in the rat. Gastroenterology. 89:1985;1114.
36. Arthur M. J. P. Reactive oxygen intermediates and liver injury. J. Hepatology. 6:1988;125.
37. Bacon B. R., Britton R. S. The pathology of hepatic iron overload: A free radical-mediated process? Hepatology. 11:1990;127.
38. Tsukamoto H. Oxidative stress, antioxidants, and alcoholic liver fibrogenesis. Alcohol. 10:1993;465.
39. Tsukamoto H., Rippe R., Niemela O., Lin M. Roles of oxidative stress in activation of Kupffer and Ito cells in liver fibrogenesis. J. Gastroenterol. Hepatol. 10:1995;S50.
40. Faruqi R., de la Motte C., DiCorleto P. E. Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J. Clin. Invest. 94:1994;592.
41. Gantner F., Leist M., Lohse A. W., Germann P. G., Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: The role of tumor necrosis factor. Hepatology. 21:1995;190.
42. Mizuhara H., Uno M., Seki N., Yamashita M., Yamaoka M., Ogawa T., Kaneda K., Fujii T., Senoh H., Fujiwara H. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Hepatology. 23:1996;1608.
43. Mochida S., Ohno A., Arai M., Fujiwara K. Role of adhesion between activated macrophages and endothelial cells in the development of two types of massive hepatic necrosis in rats. J. Gastroenterol. Hepatol. 10:1995;S38.
44. Galambos J. T., Riepe S. P. Use of colchicine and steroids in the treatment of alcoholic liver disease. Recent Dev. Alcoholism. 2:1984;181.
45. 4. Scand. J. Gastroenterol. 23:1988;931.